For investors
Request the investor pack
Tell us a little about you and we will review your request and send the pack. We review each request before sending.
We use your details only to respond to your enquiry. See our Privacy policy.
This is a request form, the pack is reviewed and sent manually by the team.
What's in the pack
- check_circle The clinical evidence summary, with sources.
- check_circle The mechanism and platform overview.
- check_circle The leadership and governance profile.
- check_circle The Australian capital and regulatory context.
- check_circle How to start a direct investor conversation.
Clinical-stage statement. Immuno1 is investigational. ImmunoPDT is a clinical-stage company. The therapy is not approved for marketing in any jurisdiction.
Forward-looking statement. This material contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties. Past clinical results are not a guarantee of future outcomes.